SENP6 and diffuse large B-cell lymphoma: To demonstrate an adverse association of SENP6 expression and susceptibility to doxorubicin (DRB), we showed that SU-DHL-5 DLBCL cells exhibited increased cell death upon DRB treatment after reconstitution of SENP6 expression (Figs. 3f and S3i).